GlassScriptPhysician profile
William D Suggs
NPI 1922180199
$4,763.74
in general payments reported to CMS, 2019-2025
41 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $559 · 2021: $665 · 2022: $679 · 2023: $527 · 2024: $853 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $749.38 | 2020-2025 | Navicross, Metacross Otw, Azur Cx Detachable |
| Cook Medical LLC | $729.18 | 2019-2025 | Zenith, Zenith Spiral-Z, Advance |
| Boston Scientific Corporation | $459.60 | 2019-2025 | General - Catheters, General - Angioplasty |
| Endologix LLC | $334.27 | 2021 | |
| Smith+Nephew, INC. | $279.11 | 2019-2025 | Collagenase Santyl, Grafix Pl, Regranex |
| Organogenesis INC. | $278.81 | 2022-2025 | Apligraf, Puraply, Puraply Wound Matrix |
| Kerecis Limited | $260.53 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Novartis Pharmaceuticals Corporation | $197.57 | 2023-2025 | |
| Imbed Biosciences INC. | $137.08 | 2022 | |
| Resmed Corp | $110.96 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.47 | 2025 | Lifevest |
| W. L. Gore & Associates, INC. | $83.35 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Celgene Corporation | $75.15 | 2024-2025 | Camzyos |
| Tactile Systems Technology INC | $67.64 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Philips North America LLC | $67.42 | 2022 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $62.22 | 2023-2024 | Jeti Peripheral Catheter, Jot Dx |
| Atricure, INC. | $62.18 | 2022 | |
| Medtronic, INC. | $58.22 | 2021-2023 | Endurant Iis |
| Integra Lifesciences Corporation | $52.02 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shockwave Medical, INC | $51.16 | 2022-2025 | |
| Angiodynamics, INC. | $48.93 | 2021 | |
| Solventum Corporation | $44.10 | 2024-2025 | Activ.A.C., Prevena, V.A.C.Ulta |
| Medicomp INC | $42.20 | 2024 | Telepatch Cardiac Monitor |
| Advanced Oxygen Therapy INC. | $40.68 | 2025 | Topical Oxygen Chamber For Extremities |
| Bard Peripheral Vascular, INC. | $34.88 | 2025 | Rotarexs 6 F X 135 Cm |
| Bioventus LLC | $32.99 | 2023 | |
| Imperative Care, INC | $31.79 | 2025 | Prodigy Catheter |
| Chiesi USA, INC. | $31.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.53 | 2022 | |
| Convatec INC. | $24.39 | 2025 | |
| Merck Sharp & Dohme LLC | $21.36 | 2023 | Bridion |
| Silk Road Medical, INC. | $21.21 | 2019 | |
| Stryker Corporation | $20.92 | 2025 | Limflow System |
| Bridgebio Pharma, INC. | $20.77 | 2025 | Attruby |
| Hydrofera LLC | $19.37 | 2023 | Hydrofera Blue |
| E.R. Squibb & Sons, L.L.C. | $19.22 | 2022 | |
| Kci USA, INC. | $18.67 | 2023 | V.A.C. Dermatac, Activ.A.C., Kerramax Care |
| Acera Surgical, INC. | $17.90 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.25 | 2024 | Farxiga |
| Electromed, INC. | $15.43 | 2019 | |
| Reprise Biomedical, INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Suggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.